GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Take Solutions Ltd (NSE:TAKE) » Definitions » Investments And Advances

Take Solutions (NSE:TAKE) Investments And Advances : ₹0.0 Mil (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Take Solutions Investments And Advances?

Take Solutions's Investments And Advances for the quarter that ended in Mar. 2024 was ₹0.0 Mil.


Take Solutions Investments And Advances Historical Data

The historical data trend for Take Solutions's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Take Solutions Investments And Advances Chart

Take Solutions Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Take Solutions Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Take Solutions Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Take Solutions (NSE:TAKE) Business Description

Traded in Other Exchanges
Address
No. 27, Tank Bund Road, Nungambakkam, Chennai, TN, IND, 600 034
Take Solutions Ltd is a technology-driven Clinical Research Organization in India. The company's operating segment includes Life Sciences and generates revenue from the Life Sciences segment. The company serves large and small biopharmaceutical companies as well as generics manufacturers.

Take Solutions (NSE:TAKE) Headlines

No Headlines